STOCK TITAN

Bowhead Specialty adds Derek Walker to board

Bowhead Specialty Holdings appointed Derek Walker as a Class II director under a nominee agreement, with his board term linked to the 2029 and 2032 stockholder meetings.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Bowhead Specialty Holdings Inc. (BOW) reports that its board of directors elected Derek Walker to the board on September 12, 2026 to fill a vacancy pursuant to GPC Partners Investments (SPV III) LP’s rights under a Board Nominee Agreement. He will serve as a Class II director, standing for reelection at the 2029 annual meeting and, if reelected, serving a term expiring at the 2032 annual meeting.

The company highlights Mr. Walker’s background as a Managing Director at Gallatin Point Capital LLC and his prior experience in private equity and investment banking, as well as multiple current and prior board roles in financial and insurance-related organizations. Because he is employed by Gallatin Point, he is not eligible to receive cash fees or other compensation for his board service, consistent with the company’s director compensation framework.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Election date September 12, 2026 Date Derek Walker was elected to the board of directors
Board Nominee Agreement date May 23, 2024 Date of the Board Nominee Agreement granting GPC Fund nomination rights
Reelection meeting year 2029 Year of the annual meeting at which Derek Walker will stand for reelection as a Class II director
Class II term expiry year 2032 Year of the annual meeting when the Class II director term is scheduled to expire
Bowhead telephone number (212) 970-0269 Company telephone number listed for Bowhead Specialty Holdings Inc.
Board Nominee Agreement regulatory
"pursuant to GPC Fund’s rights under the Board Nominee Agreement, dated as of May 23, 2024"
Class II director regulatory
"as a class II director whose term will expire at the Company's 2032 annual"
A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.
emerging growth company regulatory
"Emerging growth company T £"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
compensation committee financial
"where he is the chair of the compensation committee and previously served"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
audit and compensation committees financial
"is the chair of the audit and compensation committees, as well as a member"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did Bowhead Specialty Holdings Inc. (BOW) announce?

Bowhead Specialty Holdings Inc. announced that Derek Walker was elected to its board of directors on September 12, 2026 to fill a vacancy, pursuant to nomination rights held by GPC Partners Investments (SPV III) LP under a Board Nominee Agreement dated May 23, 2024.

What is Derek Walker’s board term structure at Bowhead Specialty (BOW)?

Derek Walker will serve as a Class II director. He will stand for reelection at Bowhead Specialty’s 2029 annual meeting of stockholders, and the Class II director term is scheduled to expire at the company’s 2032 annual meeting of stockholders.

Will Derek Walker receive director compensation from Bowhead Specialty (BOW)?

No. Because Derek Walker is employed by Gallatin Point Capital LLC, he is not eligible to receive cash fees or other forms of compensation for his board service at Bowhead Specialty, consistent with the company’s director compensation approach described in its March 16, 2026 proxy statement.

What is Derek Walker’s professional background relevant to Bowhead Specialty (BOW)?

Derek Walker is a Managing Director at Gallatin Point Capital LLC. His prior roles include Private Equity Associate at Thomas H. Lee Partners and Investment Banking Analyst at J.P. Morgan. He also serves on several financial and insurance company boards, including Forbright Bank (NASDAQ: FRBT).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0002002473false00020024732026-09-122026-09-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 12, 2026
Bowhead Specialty Holdings Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-42111
87-1433334
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
452 Fifth Avenue
New York, New York 10018
(Address of principal executive offices)
(212) 970-0269
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
£    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
BOW
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 under the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company T
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. £



Item 5.02     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 12, 2026, the board of directors (the “Board”) of Bowhead Specialty Holdings Inc. (the “Company”) elected Derek Walker to the Board, effective September 12, 2026. Mr. Walker, was recommended to serve on the Board by GPC Partners Investments (SPV III) LP’s (“GPC Fund”) pursuant to GPC Fund’s rights under the Board Nominee Agreement, dated as of May 23, 2024, between the Company and GPC Fund, to fill the vacancy on the Board.

Mr. Walker will serve until his successor is duly qualified or until his death, resignation or removal, whichever is earliest to occur. Mr. Walker will stand for reelection at the Company's annual meeting of stockholders to be held in 2029 as a class II director whose term will expire at the Company's 2032 annual meeting of stockholders.

Mr. Walker is a Managing Director at Gallatin Point Capital LLC (“Gallatin Point”) and has worked at the firm since 2019. Prior to joining Gallatin Point, Mr. Walker served as a Private Equity Associate at Thomas H. Lee Partners from July 2015 to July 2017, and an Investment Banking Analyst in the Financial Institutions Group at J.P. Morgan from June 2013 to June 2015. Mr. Walker currently serves as a member of the board of directors for Forbright Bank (NASDAQ: FRBT), where he is the chair of the compensation committee and previously served as a member of the directors’ compliance committee. Mr. Walker further serves as a member of the board of directors for DS2 Capital and is the chair of the audit and compensation committees, as well as a member of the risk committee. Mr. Walker also currently serves on the board of directors for Pie Insurance, Trusted Resource Underwriters Exchange, and Insurance Supermarket, a digital life insurance distribution platform. Mr. Walker formerly served as a Director at First Investors, an auto finance originator and servicer. Mr. Walker received a B.A. (magna cum laude, phi beta kappa) with distinction in Economics from Yale University and an M.B.A. (Arjay Miller Scholar) from Stanford University Graduate School of Business. We believe that Mr. Walker is qualified to serve on the Board because of his extensive investment and management experience.

Mr. Walker is employed by Gallatin Point and is not eligible to receive any cash fees or other forms of compensation in connection with his service on the Board, as described under the caption “Board of Directors and Corporate Governance–Director Compensation” in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on March 16, 2026, as adjusted by the Board from time to time.
2


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 14, 2026
By:
/s/ H. Matthew Crusey
Name:
H. Matthew Crusey
Title:
General Counsel and Secretary

Filing Exhibits & Attachments

3 documents

Keep reading